Ma, Y., Feng, Q., Han, B., Yu, R., & Jin, Z. (2023). Elevated HMGB1 promotes the malignant progression and contributes to cisplatin resistance of non-small cell lung cancer. Hereditas, 160(1), 1. https://doi.org/10.1186/s41065-023-00294-9
Chicago-referens (17:e uppl.)Ma, Ying, Qin Feng, Bateer Han, Rong Yu, och Zhiyong Jin. "Elevated HMGB1 Promotes the Malignant Progression and Contributes to Cisplatin Resistance of Non-small Cell Lung Cancer." Hereditas 160, no. 1 (2023): 1. https://doi.org/10.1186/s41065-023-00294-9.
MLA-referens (9:e uppl.)Ma, Ying, et al. "Elevated HMGB1 Promotes the Malignant Progression and Contributes to Cisplatin Resistance of Non-small Cell Lung Cancer." Hereditas, vol. 160, no. 1, 2023, p. 1, https://doi.org/10.1186/s41065-023-00294-9.
